Education
About Us
Working with TipRanks
Follow Us
Innate Pharma S.A. (FR:IPH)
:IPH
Iph4502
Advanced Or Metastatic Solid Tumors
Phase I
Recruiting
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
Jan 08, 2025
―
Iph6501
Non Hodgkin Lymphoma
Phase I/II
Recruiting
Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma
Oct 12, 2023
―
Iph5201 + Durvalumab + Standard Chemotherapy
Non Small Cell Lung Cancer
Phase II
Recruiting
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Feb 15, 2023
―
Iph4102
Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Mycosis Fungoides/Sezary Syndrome
Phase II
Active Not Recruiting
IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma
Mar 14, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Innate Pharma S.A. (IPH) have in its pipeline
IPH is currently developing the following drugs: Iph4502, Iph6501, Iph5201 + Durvalumab + Standard Chemotherapy. These drug candidates are in various stages of clinical development as the company works toward FDA approval.